Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Angle Closure Glaucoma: Treatment

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

Open Angle Glaucoma: Treatment

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

Ophthalmic Drug Delivery Systems

Ophthalmic Drug Delivery Systems

Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Definition and Diagnostic Criteria for Pediatric Blepharokeratoconjunctivitis.

JAMA ophthalmology·2023

Same author

IMI Prevention of Myopia and Its Progression.

Investigative ophthalmology & visual science·2021

Same author

Rabbit Fungal Keratitis Model of Fusarium solani Tested Against Three Commercially Available Antifungal Drugs.

Eye & contact lens·2020

Same author

Eighteen-year prospective audit of LASIK outcomes for myopia in 53 731 eyes.

The British journal of ophthalmology·2018

Same author

Semisynthetic Flavone-Derived Antimicrobials with Therapeutic Potential against Methicillin-Resistant Staphylococcus aureus (MRSA).

Journal of medicinal chemistry·2017

Same author

Upregulation of distinct collagen transcripts in post-surgery scar tissue: a study of conjunctival fibrosis.

Disease models & mechanisms·2017

Search research articles

Related Experiment Video

Updated: Jul 14, 2026

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

Current concepts and techniques in pterygium treatment.

Leonard P K Ang¹, Jocelyn L L Chua, Donald T H Tan

¹Singapore National Eye Centre, Singapore. leopk@pacific.net.sg

Current Opinion in Ophthalmology

|June 15, 2007

Summary

Pterygium treatment options are varied, with conjunctival autografting and mitomycin C being common for preventing recurrence. Further trials are needed to confirm the best methods for pterygium management.

Related Experiment Videos

Last Updated: Jul 14, 2026

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

Area of Science:

Ophthalmology
Ocular surface disease

Background:

Pterygium is a prevalent ocular condition globally.
Optimal treatment guidelines for primary or recurrent pterygium are lacking.
Current surgical methods for pterygium are diverse.

Purpose of the Study:

To review recent studies on pterygium treatment.
To summarize current concepts and techniques for pterygium management.

Main Methods:

Literature review of recent and relevant studies on pterygium treatment.
Analysis of surgical techniques and adjunctive therapies.

Main Results:

Pterygium excision aims to prevent recurrence, often using conjunctival autografts or mitomycin C.
No consensus exists on the ideal pterygium treatment.
Varied definitions of recurrence hinder study comparability.

Conclusions:

Conjunctival autografting and mitomycin C are frequently used to prevent pterygium recurrence.
Mitomycin C and beta-irradiation require cautious use due to potential sight-threatening complications.
More clinical trials are necessary to assess treatment efficacy and long-term safety.